[Nirmatreolvir-ritonavir (Paxlovid) leads to no reduction of symptoms or hospitalizations in vaccinated or unvaccinated high-risk adults with Covid-19.]

Subjects

Subjects :

Humans
Drug Combinations
Adult
Male
COVID-19 Vaccines administration & dosage
Middle Aged
COVID-19 prevention & control
Female
Aged
Antiviral Agents administration & dosage
Treatment Outcome
Ritonavir administration & dosage
Hospitalization statistics & numerical data
COVID-19 Drug Treatment

Details

Language :

Italian

ISSN :

2038-1840

Volume :

115

Issue :

9

Database :

MEDLINE

Journal :

Recenti progressi in medicina

Publication Type :

Academic Journal

Accession number :

39269351

Full Text :

https://doi.org/10.1701/4334.43178